Literature DB >> 18471421

[Clinical observation of Astragalus Injection in treatment of renal injury in patients with primary hypertension].

Gui-Hua Xu1, Li Yuan, Yan Li, Ping Xie, Jin-Yuan Zhao, Yong-Hua Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18471421     DOI： 10.3736/jcim20080519

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN： 1672-1977


× No keyword cloud information.
  3 in total

1.  Astragalus membranaceus Injection Suppresses Production of Interleukin-6 by Activating Autophagy through the AMPK-mTOR Pathway in Lipopolysaccharide-Stimulated Macrophages.

Authors:  Xiaoyan Zhang; Taigang Liang; Wanxia Yang; Lanfang Zhang; Shuting Wu; Chaoqun Yan; Qingshan Li
Journal:  Oxid Med Cell Longev       Date:  2020-07-04       Impact factor: 6.543

2.  Inhibition of miRNA-1-Mediated Inflammation and Autophagy by Astragaloside IV Improves Lipopolysaccharide-Induced Cardiac Dysfunction in Rats.

Authors:  Qiuning Wang; Weiying Chen; Xuefeng Yang; Ying Song; Xiaowei Sun; Guizhou Tao; Hong Wang; Nan Zhao; Yue Huang; Erqing Chai; Futian Tang
Journal:  J Inflamm Res       Date:  2022-04-23

3.  Astragalus injection for hypertensive renal damage: a systematic review.

Authors:  Tian Sun; Hao Xu; Fengqin Xu
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-19       Impact factor: 2.629
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.